By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genzyme and Veracyte today announced a co-marketing deal covering Veracyte's thyroid diagnostic tool.

Under the terms of the deal, Genzyme will market and promote Veracyte's Afirma Thyroid FNA Analysis solution in the US initially and then globally. Other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.